The latest announcement is out from Tonix Pharma (TNXP).
Tonix Pharmaceuticals Holding Corp. is gearing up for the U.S. launch and commercialization of its product candidate Tonmya™, having appointed Almac Pharma Services as one of the two contract manufacturers. These preparations come with a forward-looking perspective, highlighting the company’s expectations for product development and market opportunities. However, investors are reminded that these plans are subject to the usual risks and uncertainties inherent in the pharmaceutical industry, and actual results may vary.
See more insights into TNXP stock on TipRanks’ Stock Analysis page.
